BioSpace News Archive

BrainsWay Ltd. today announced a preliminary, unaudited revenue range for the first quarter ended March 31, 2020. Specifically, the Company expects first quarter revenues to be within the range of $3.9 million to $4.2 million. “Our revenue estimate for the first quarter reflects the impact that the COVID-19 gl

CytoSorbents Corporation , announced the United States Food and Drug Administration (FDA) has granted product use in patients with COVID-19

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the company has completed enrollment in their DISRUPT CAD IV study of IVL in heavily calcified coronary arteries that is intended to support regulatory device approval in Japan.

PetVivo Holdings, Inc. (OTCQB: PETV) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets is pleased to announce a new social media engagement campaign to increase transparency with its stakeholders. 2020 started off strong with great positioning of our lead product Kush ® , paired with excellent responses from veterinarians and expan

Clinical Plan Includes Healthy Volunteers in New Zealand and OTC-Deficient Patients Across Several Sites in United States Investor Conference Call at 4:00 pm ET Today SAN DIEGO, April 13, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (the “Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, today announced the acceptance of two clinical trials for it

Ascletis Pharma Inc. (HKEX code: 1672) announces today that it received IND approval from National Medical Products Administration (NMPA) for its human immunodeficiency virus (HIV) protease inhibitor ASC09F (ASC09/Ritonavir Fixed-Dose Combination). ASC09 has an unprecedented high genetic barrier to resistance and

Grant supports 18 labs working round the clock; expands longstanding partnership

All-Digital Automated Scanning and AI-Powered Analysis Enables Precise and Comprehensive Diagnosis, Remote Consultation and Accelerated Results to Improve Care Outcomes

Maxim Integrated Products, Inc. (NASDAQ: MXIM) has accelerated the production of its medical technologies to address increased customer need during the COVID-19 pandemic. The company’s semiconductor devices are used in medical equipment such as virus detection devices, ultrasounds, analytical/laboratory equipment, ventilators, pat

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that results from the CONVERGE IDE trial have been accepted for presentation in the late-breaking abstract sessions at the Heart Rhythm Society (HRS) Scientific Sessions. The abstract will be presented as a webinar on Heart Rhythm 365, the society’s digital informati